Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses

Globally, there is an urgency to develop effective, low-cost therapeutic interventions for coronavirus disease 2019 (COVID-19). We previously generated the stable and ultrapotent homotrimeric Pittsburgh inhalable Nanobody 21 (PiN-21). Using Syrian hamsters that model moderate to severe COVID-19 dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Nambulli, Sham, Xiang, Yufei, Tilston-Lunel, Natasha L., Rennick, Linda J., Sang, Zhe, Klimstra, William B., Reed, Douglas S., Crossland, Nicholas A., Shi, Yi, Duprex, W. Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153718/
https://www.ncbi.nlm.nih.gov/pubmed/34039613
http://dx.doi.org/10.1126/sciadv.abh0319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153718/
https://www.ncbi.nlm.nih.gov/pubmed/34039613
http://dx.doi.org/10.1126/sciadv.abh0319

Ejemplares similares